IEL Information

IEL an Advanced Accelerator and Novartis company is proud to be a distributor of international medical equipment for medical physics environments, including radiotherapy physics, diagnostic radiology, nuclear medicine, radiopharmaceuticals, radiation safety and radiation protection products. AAA's main focus is in the field of Molecular Imaging and targeted individualised therapy for the management of patients with serious conditions (Personalised Medicine). IEL represents over 35 manufacturers and specialises in the effective use of radiation in medicine for both diagnostic and therapeutic purposes. Its successful relationships with manufacturers is based on the sharing of customer feedback and joint commitment to good customer service. IEL has developed a strong reputation for bringing innovative products to the UK and Ireland and helping customers make the best use of their equipment. AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology. AAA also produces a broad range of SPECT products. AAA currently has 18 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 400 employees in 12 countries (France, Italy, UK, Germany, Switzerland, Spain, Poland, Portugal, The Netherlands, Israel, United States and Canada).